| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/25/2007 | US20070248535 Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity |
| 10/25/2007 | CA2650998A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer |
| 10/25/2007 | CA2650140A1 Identifying and modulating molecular pathways that mediate nervous system plasticity |
| 10/25/2007 | CA2649847A1 Novel enterococcus and streptococcus strains and bacteriocins |
| 10/25/2007 | CA2649768A1 Use of trap protein per se as an active ingredient for the manufacture of a medicament for the treatment of staphylococcus aureus infection |
| 10/25/2007 | CA2649480A1 Antibacterial compounds comprising multiple thiazole rings isolated fromkocuria species |
| 10/25/2007 | CA2649440A1 Methods of treating autoimmune diseases |
| 10/25/2007 | CA2649303A1 Homogeneous erythropoietin and other peptides and proteins, methods and intermediates for their preparation |
| 10/25/2007 | CA2649109A1 Rapid acting and long acting insulin combination formulations |
| 10/25/2007 | CA2649073A1 Compositions and methods for suppression of amyloid plaque formation associated with neurodegenerative disorders |
| 10/25/2007 | CA2648678A1 Hcv inhibitors |
| 10/25/2007 | CA2648440A1 Pharmaceutical compositions of hglp-1, exendin-4 and analogs thereof |
| 10/25/2007 | CA2648298A1 Organic compounds and their uses |
| 10/25/2007 | CA2648164A1 Lysobactin amides |
| 10/25/2007 | CA2646400A1 Glucagon-like peptide 1(glp-1) pharmaceutical formulations |
| 10/25/2007 | CA2645766A1 Immunogenic wt-1 peptides and methods of use thereof |
| 10/24/2007 | EP1847614A1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virions (raav virions), and method and use for treating amino acid metabolic disorders using such raav virions |
| 10/24/2007 | EP1847608A1 Member of the TNF ligand family |
| 10/24/2007 | EP1847607A1 Human p51 protein and antibody |
| 10/24/2007 | EP1847606A2 Mitogenic regulators |
| 10/24/2007 | EP1847600A1 Specific protease for inactivation of human tumour necrosis factor-alpha |
| 10/24/2007 | EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 10/24/2007 | EP1847273A1 April receptor (BCMA) and uses thereof |
| 10/24/2007 | EP1846550A2 Use of the mcm8 gene for the preparation of a pharmaceutical composition |
| 10/24/2007 | EP1846446A1 Insulin derivatives |
| 10/24/2007 | EP1846445A1 Pyy agonists and uses thereof |
| 10/24/2007 | EP1846444A2 Agents inhibiting the cathelin-like protein cap18/ll-37 |
| 10/24/2007 | EP1846443A2 Novel use |
| 10/24/2007 | EP1846439A2 Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants |
| 10/24/2007 | EP1846438A2 Methods and means for use in diagnostics and treatment of diabetes |
| 10/24/2007 | EP1846107A1 Neuroprotective agents and methods of their use |
| 10/24/2007 | EP1846036A1 Reducing drug dependence or addiction |
| 10/24/2007 | EP1846034A2 Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists |
| 10/24/2007 | EP1846022A2 Methods for treating adhesive capsulitis |
| 10/24/2007 | EP1846021A2 Novel method for treating chronic severe heart failure by using insulin-like growth factor-1 (igf-1) |
| 10/24/2007 | EP1846020A2 Methods for treating renal cell carcinoma |
| 10/24/2007 | EP1846019A2 Method for treating cardiovascular disease |
| 10/24/2007 | EP1846018A1 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
| 10/24/2007 | EP1846017A1 Angiotensin i derivatives |
| 10/24/2007 | EP1846016A2 Methods of increasing cerebral blood flow |
| 10/24/2007 | EP1846015A2 Method, compositions and classification for tumor diagnostics and treatment |
| 10/24/2007 | EP1846014A2 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally senstive transmembrane peptide |
| 10/24/2007 | EP1846013A2 Treatment of skin diseases |
| 10/24/2007 | EP1845974A1 Pharmaceutical compounds |
| 10/24/2007 | EP1845944A2 Pharmaceutical compositions |
| 10/24/2007 | EP1845925A2 Method for delivering interferon- |
| 10/24/2007 | EP1845797A1 Food products comprising hydrolysed milk solids with improved taste |
| 10/24/2007 | EP1670493A4 In vitro development of tissues and organs |
| 10/24/2007 | EP1478343A4 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment |
| 10/24/2007 | EP1432728A4 Methods and compositions for treating inflammatory disorders |
| 10/24/2007 | EP1366151B1 Prna chimera |
| 10/24/2007 | EP1311281B1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 10/24/2007 | EP1156797B1 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 10/24/2007 | EP1121431B9 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 10/24/2007 | EP0723588B1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family |
| 10/24/2007 | CN101061135A Synthetic peptides capable of reducing or removing eye-bag formed under lower orbital and their application in cosmetic or dermo-phamaceutical composition |
| 10/24/2007 | CN101061134A Novel topical application agents against mimic and age-related wrinkles |
| 10/24/2007 | CN101060857A Medicament |
| 10/24/2007 | CN101060856A Soluble, stable insulin-containing formulations with a protamine salt |
| 10/24/2007 | CN101060855A Gastrointestinal proliferative factor and uses thereof |
| 10/24/2007 | CN101060854A Protein hydrolysate with antidiabetic effect |
| 10/24/2007 | CN101058808A Breast cancer relevant p69 gene, coding protein and application thereof |
| 10/24/2007 | CN101058604A FK gene, coding protein and application thereof |
| 10/24/2007 | CN101058603A SIP45 gene, coding protein and application thereof |
| 10/24/2007 | CN101058602A Rana grahami boulenger antibiotic peptide, preparation method and application thereof |
| 10/24/2007 | CN101058601A Horseshoe crab anti-endotoxin factor analogue peptide molecule, synthetic method and use thereof |
| 10/24/2007 | CN101058600A Oxidation resistance zymolyte rich in pollen active peptide |
| 10/24/2007 | CN101058599A Application of thymidylate synthase mRNA used as tumour therapeutic agent for disturbing peptide |
| 10/24/2007 | CN101057976A Substances for preventing and treating autoimmune diseases |
| 10/24/2007 | CN101057972A Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
| 10/24/2007 | CN101057971A Medicine for controlling livestock-poultry virus infectious disease |
| 10/24/2007 | CN101057969A Suppository for treating wound caused by cervical erosion treatment |
| 10/24/2007 | CN101057968A Oxyntomodulin for preventing or treating excess weight |
| 10/24/2007 | CN101057967A Stabilized interferon compositions |
| 10/24/2007 | CN101057966A Liposome nanometer carrier situ gel preparation used for eye epidermal growth factor |
| 10/24/2007 | CN101057965A Compound traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular disease |
| 10/24/2007 | CN101057964A Application of marasmius androsaceus glycoprotein in medicine making |
| 10/24/2007 | CN101057864A Technology for preparing anti influenza virus transfer factors |
| 10/24/2007 | CN101057832A Method for preparing protein or polypeptide medicine slow-releasing microball |
| 10/24/2007 | CN101057829A Supersaturated cationic self-emulsified drug delivery system and its preparation method |
| 10/24/2007 | CN100344970C Treatment and diagnosis of cancer |
| 10/24/2007 | CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 10/24/2007 | CN100344646C Oligonucleotide-containing pharmacological compositions and their use |
| 10/24/2007 | CN100344326C Iron-supplementing preparation |
| 10/24/2007 | CN100344325C Medicine for treating cervical carcinoma, its preparation process and application |
| 10/24/2007 | CN100344324C Cream of liposome of interferon |
| 10/24/2007 | CN100344323C Human glucagon-like peptide-1 compound and its preparing method |
| 10/24/2007 | CN100344293C Polymeric micelle containing cisplatin enclosed therein and use thereof |
| 10/23/2007 | US7285654 Stimulus-inducible protein kinase complex and methods of use therefor |
| 10/23/2007 | US7285650 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy |
| 10/23/2007 | US7285646 Has an iron binding capacity of at least 1.0 mg-per gram of protein, is non-pyrogenic and is pathogen free; preparation by anion exchange chromatography |
| 10/23/2007 | US7285644 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2007 | US7285642 Composition and method for modulating dendritic cell-T cell interaction |
| 10/23/2007 | US7285639 Antibody to telomerase reverse transcriptase |
| 10/23/2007 | US7285638 Removing the scales, gills, and meat tissue from the fish skin using wooden and glass tools; hydrating the skin in a glass container containing lactic acid solution; and repeatedly filtering the solution with natural silk filters that have a similar structure to the collagen |
| 10/23/2007 | US7285636 Vectors with DNA encoding pro polypeptides |
| 10/23/2007 | US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity |
| 10/23/2007 | US7285633 Metalloprotease highly expressed in the testis, MMP-29 |
| 10/23/2007 | US7285631 Forsenic analysis; medical diagnosis; chromosome markers |
| 10/23/2007 | US7285630 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |